Wednesday, June 10, 2026

pharma

CIS bio international

CIS bio international drug portfolio β€” 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

SACLAY, FR HQ
EMA registrant Type
Company details
Status
Public
HQ
SACLAY, FR
Programs
0
Drugs
0
Patents
18
Intelligence Β· Drug Pipeline

CIS bio international pipeline

Portfolio lens on 0 drugs and development assets β€” regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

CIS bio international drug portfolio β€” 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects β†’